retatrutide type 2 diabetes phase 2 trial results ๐จ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ retatrutide #type2diabetes #obesity #weightreduction #hba1c
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 28 - Sep 2

























